Mycobacterial Diseases
Open Access

Jobran Miree Alqahtani

Publications

• Research Article
  Anti-Tuberculous Drugs and Susceptibility Testing Methods: Current Knowledge and Future Challenges
  Author(s): Jobran Miree Alqahtani and Ahmed Morad AsaadJobran Miree Alqahtani and Ahmed Morad Asaad
  
  The emergence of multi-drug resistant tuberculosis (MDR-TB) outbreaks during 1990s and more recently the highly lethal strains of extensively drug-resistant TB (XDR-TB) is hampering efforts to control and manage tuberculosis (TB), and also threatening World Health Organization’s target of TB elimination by 2050. The TB community has promoted a full pipeline of candidate for the new TB drugs at all phases of development. The majority of candidates are in preclinical and early clinical development. The challenge of conducting these trials, especially that they will be conducted in resource-poor locations with limited infrastructure or trials experience will be considerable. New tuberculosis drug regimens are creating new priorities for drug susceptibility testing (DST) and surveillance. To minimize turnaround time, rapid and sensitive DST will need to be prioritized, but developer.. View More»
  DOI: 10.4172/2161-1068.1000140

  Abstract PDF

Relevant Topics